ProCE Banner Series

Contemporary HIV Treatment and Prevention 2024

In this engaging meeting series available throughout the United States, expert faculty review key data informing the optimal use of contemporary HIV treatment and prevention. Full details of the many available topics are provided below.

To Host an Event
You know best what educational topic(s) would be most valuable in your local area, so let us know and we can arrange the details. We will work with you to choose the topic, date/time, and speaker. On the day of the meeting, you will introduce the speaker and help lead the discussion. There will be no cost to the host or the attendees.

Please contact us at meetings@clinicaloptions.com to learn more.

Program Directors:

  • Monica Gandhi, MD, MPH
  • Jeffrey Kwong, DNP, MPH, AGPCNP-BC
  • Nimish Patel, PharmD, PhD, AAHIVP

 Core Faculty:

  • Isolde F. Butler, MD, MPH
  • Latesha Elopre, MD, MSPH
  • Daniel R. Kuritzkes, MD
  • David Alain Wohl, MD
  • Darcy Wooten, MD, MS
  ACPE
  | AMA
  | ANCC
Who Should Attend

This program is intended for physicians, registered nurses, nurse practitioners, physician associates, pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection.

All Events

Upcoming Events

May

24

2024

Contemporary HIV Treatment and Prevention 2024 - Optimizing ART for Priority Populations

1:30 PM - 2:30 PM Central Time (CT)

In-person

June

11

2024

Contemporary HIV Treatment and Prevention 2024 - Beyond Viral Suppression: Experts Strategies to Improve Patient Outcomes

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

June

22

2024

Contemporary HIV Treatment and Prevention 2024 - Overcoming Barriers to PrEP Uptake

9:00 AM - 10:00 AM Eastern Time (ET)

Virtual

July

08

2024

Contemporary HIV Treatment and Prevention 2024 - Implementing LA ART in Clinical Practice

10:30 AM - 11:30 AM Eastern Time (ET)

Virtual

July

20

2024

Contemporary HIV Treatment and Prevention 2024 - Optimizing ART for Priority Populations

9:00 AM - 10:00 AM Eastern Time (ET)

Virtual

August

23

2024

Contemporary HIV Treatment and Prevention 2024 - Overcoming Barriers to PrEP Uptake

12:30 PM - 1:30 PM Eastern Time (ET)

In-person

August

29

2024

Contemporary HIV Treatment and Prevention 2024 - Beyond Viral Suppression: Experts Strategies to Improve Patient Outcomes

12:00 PM - 1:00 PM Eastern Time (ET)

In-person

Past Events

February

21

2024

Contemporary HIV Treatment and Prevention 2024 - Optimizing ART for Priority Populations

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

February

28

2024

Contemporary HIV Treatment and Prevention 2024 - Optimizing ART for Priority Populations

8:00 AM - 9:00 AM Central Time (CT)

Virtual

March

14

2024

Contemporary HIV Treatment and Prevention 2024 - Optimizing ART for Priority Populations

8:00 AM - 9:00 AM Eastern Time (ET)

Virtual

March

19

2024

Contemporary HIV Treatment and Prevention 2024 - Beyond Viral Suppression: Experts Strategies to Improve Patient Outcomes

12:00 PM - 1:00 PM Central Time (CT)

Virtual

April

16

2024

Contemporary HIV Treatment and Prevention 2024 - Implementing LA ART in Clinical Practice

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

April

23

2024

Contemporary HIV Treatment and Prevention 2024 - Overcoming Barriers to PrEP Uptake

7:00 AM - 8:00 AM Central Time (CT)

Virtual

May

15

2024

Contemporary HIV Treatment and Prevention 2024 - Overcoming Barriers to PrEP Uptake 

12:00 PM - 1:00 PM Central Time (CT)

Virtual

Faculty

ProCE Banner Faculty
Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier, Jr., MD Education Director and Professor of Internal Medicine
Chair, Department of Clinical Sciences
Florida State University College of Medicine
Medical Director
Care Point Health and Wellness
Tallahassee, Florida 

ProCE Banner Faculty
Roger Bedimo, MD, MS, FACP

Professor of Medicine
Interim Director, Office of Global Health
UT Southwestern Medical Center
Chief, Infectious Diseases Section
VA North Texas Health Care System
Dallas, Texas

ProCE Banner Faculty
Kassem Bourgi, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Indiana University School of Medicine
Indianapolis, Indiana

ProCE Banner Faculty
Latesha Elopre, MD, MSPH

Scientific and Medical Consultant
Associate Professor of Medicine
Division of Infectious Diseases
Assistant Dean for Diversity and Inclusion
Medical Education
University of Alabama at Birmingham
Birmingham, Alabama

ProCE Banner Faculty
Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

ProCE Banner Faculty
Geeta Gupta, MD

Director, Pacific AIDS Education and Training Center
Professor, Infectious Diseases
University of California Irvine Medical Center
Orange, California

ProCE Banner Faculty
Jason Halperin, MD, MPH, FIDSA

Director of Specialty Programs
DAP Health
Cathedral City, California

ProCE Banner Faculty
W. David Hardy, MD, AAHIVS

Scientific and Medical Consultant
Adjunct Clinical Professor of Medicine
Division of Infectious Diseases
Keck School of Medicine of USC
Los Angeles, California

ProCE Banner Faculty
Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, Illinois

ProCE Banner Faculty
Dushyantha T. Jayaweera, MD, MRCOG (UK), FACP

Professor of Medicine
Miller School of Medicine
Schiff Center for Liver Diseases
University of Miami
Interdisciplinary Stem Cell Institute
Miami, Florida

ProCE Banner Faculty
Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

ProCE Banner Faculty
Sarah Rowan, MD

Associate Professor of Medicine 
Division of Infectious Diseases 
University of Colorado School of Medicine 
Aurora, Colorado 
Associate Director of HIV and Viral Hepatitis Prevention 
Public Health Institute at Denver Health 
Denver Health and Hospital Authority 
Denver, Colorado

ProCE Banner Faculty
Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases
Brigham and Women’s Hospital
Bruce A. and Robert L. Beal Distinguished Chair in Infectious Diseases
Professor of Medicine, Harvard Medical School
Boston, Massachusetts

ProCE Banner Faculty
Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

ProCE Banner Faculty
William R. Short, MD, MPH, FIDSA

Associate Director of the HIV Clinical Trials Unit
Associate Professor of Medicine
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

ProCE Banner Faculty
Timothy J. Wilkin, MD, MPH

Professor of Medicine
Division of Infectious Diseases
Weill Cornell Medicine
New York, New York

ProCE Banner Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Topics

Specific meetings can focus on any of the following:

  • Optimizing ART for Priority Populations
  • Implementing LA ART in Clinical Practice
  • Beyond Viral Suppression: Expert Strategies to Improve Patient Outcomes
  • Overcoming Barriers to PrEP Uptake
  • CROI 2024 Update: What Did We Learn?
  • AIDS 2024 Update: What Did We Learn?

The timing and agenda for each individual meeting is as follows:

  • Welcome, CME information, and baseline outcomes questions (5 mins)
  • Case discussions and didactic slides with concluding outcomes questions (40 min)
  • Question and answer session (15 mins)

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary antiretroviral regimens.

Target Audience
This program is intended for physicians, registered nurses, nurse practitioners, physician associates, pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

CROI 2024 Update: What Did We Learn?

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents
  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies
  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

AIDS 2024 Update: What Did We Learn?

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents
  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies
  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Optimizing ART for Priority Populations

  • Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
  • Apply strategies to individualize ART in specific population subgroups

Beyond Viral Suppression: Expert Strategies to Improve Patient Outcomes

  • Assess whether ART changes can be considered to improve quality of life in the setting of viral suppression
  • Apply strategies to engage effectively with patients to understand their perspectives and improve their satisfaction with their HIV care

Implementing Long-Acting ART in Clinical Practice

  • Integrate strategies to proactively consider patient candidacy for long-acting ART, administer it appropriately, support patient adherence to dosing visits, and minimize barriers to uptake and adverse events
  • Describe the considerations for initiation and use of long-acting injectable ART for PrEP
  • Select an appropriate initial ART regimen for a patient experiencing seroconversion who was previously receiving long-acting PrEP

Overcoming Barriers to PrEP Uptake

  • Identify barriers to PrEP uptake
  • Employ practical strategies to increase PrEP use among those for whom it is recommended

Accreditation

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number – Specific to each topic

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with HealthHIV

Supported by an educational grant from ViiV Healthcare.